Bausch + Lomb adquire produtos oftalmológicos da Novartis por US$ 1,75 bilhão, impulsionando as ações

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Bausch + Lomb adquire produtos oftalmológicos da Novartis por US$ 1,75 bilhão, impulsionando as ações

/jornal/2023/06/bausch-lomb-adquire-produtos-oftalmologicos-da-novartis-por-us-1-75-bilhao-impulsionando-as-acoes/

Novartis (BOV:N1VS34)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Novartis Charts.

Novartis (BOV:N1VS34)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Novartis Charts.

News

More News Articles

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

Good Vibrations Shoes (PK)

KULR Technology

North Bay Resources (PK)

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Hallmark Venture (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions